Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>HER2</i> genetic heterogeneity in breast carcinoma

19 Oct 2011

Abstract excerpt

AIMS: To determine the frequency of HER2 genetic heterogeneity according to the recent American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) definition (2009) in invasive breast carcinoma, and to identify clinicopathological features that characterise breast carcinomas with HER2 genetic heterogeneity. METHODS: 530 invasive breast carcinomas were retrospectively analysed for HER2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Breast Cancer Treatment Studies
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22011446
DOI: 10.1136/jclinpath-2011-200265

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>HER2</i> genetic heterogeneity in breast carcinomaPMID 22011446Read ↗

<i>HER2</i> Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast CancerSemantic proximity Read ↗

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.Semantic proximity Read ↗

Genetic Heterogeneity in HER2 Testing in Breast Cancer: Panel Summary and GuidelinesSemantic proximity Read ↗

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.Semantic proximity Read ↗

Tumor Heterogeneity in Breast CancerSemantic proximity Read ↗

Breast Cancer Heterogeneity and Response to Novel TherapeuticsSemantic proximity Read ↗

Tumor Heterogeneity in Breast Cancer.Semantic proximity Read ↗

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity.Semantic proximity Read ↗

Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumorsSemantic proximity Read ↗

Intratumor heterogeneity defines treatment‐resistant HER 2+ breast tumorsSemantic proximity Read ↗

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatmentSemantic proximity Read ↗

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.